| Role for DNA damage signaling in pulmonary arterial hypertension J Meloche, A Pflieger, M Vaillancourt, R Paulin, F Potus, S Zervopoulos, ... Circulation 129 (7), 786-797, 2014 | 243 | 2014 |
| Downregulation of microRNA-126 contributes to the failing right ventricle in pulmonary arterial hypertension F Potus, G Ruffenach, A Dahou, C Thebault, S Breuils-Bonnet, ... Circulation 132 (10), 932-943, 2015 | 207 | 2015 |
| LAG3’s enigmatic mechanism of action CG Graydon, S Mohideen, KR Fowke Frontiers in immunology 11, 615317, 2021 | 129 | 2021 |
| Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension F Potus, S Malenfant, C Graydon, V Mainguy, E Tremblay, ... American journal of respiratory and critical care medicine 190 (3), 318-328, 2014 | 129 | 2014 |
| Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series) F Potus, C Graydon, S Provencher, S Bonnet Pulmonary Circulation 4 (2), 175-184, 2014 | 60 | 2014 |
| Roles, function and relevance of LAG3 in HIV infection CG Graydon, AL Balasko, KR Fowke PLoS pathogens 15 (1), e1007429, 2019 | 41 | 2019 |
| miRNAs in PAH: biomarker, therapeutic target or both? J Meloche, A Pflieger, M Vaillancourt, C Graydon, S Provencher, S Bonnet Drug discovery today 19 (8), 1264-1269, 2014 | 33 | 2014 |
| Granzyme B deficiency exacerbates lung inflammation in mice after acute lung injury JA Hirota, PR Hiebert, M Gold, D Wu, C Graydon, JA Smith, K Ask, ... American journal of respiratory cell and molecular biology 49 (3), 453-462, 2013 | 27 | 2013 |
| Banding profile of rep-PCR experiments differs with varying extension times and annealing temperatures D Korvin, C Graydon, L McNeil, M Mroczek Journal of Experimental Microbiology and Immunology 18, 146-149, 2014 | 8 | 2014 |
| The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant natural killer T cell function AL Balasko, MM Kowatsch, C Graydon, J Lajoie, KR Fowke Scientific Reports 13 (1), 10082, 2023 | 3 | 2023 |
| Novel in vitro invariant Natural Killer T cell functional assays A Balasko, C Graydon, KR Fowke Journal of Immunological Methods 499, 113171, 2021 | 3 | 2021 |
| Strategies to increase productivity, improve performance, and decrease stress levels in surgical training: perspectives from the younger generation R Wagner, C Graydon, OJ Deffaa Annals of Surgery 269 (5), 810-811, 2019 | 2 | 2019 |
| Mir‐126 dependent alteration of angiogenesis contributes to right ventricle failure in pulmonary arterial hypertension (868.2) F Potus, C Graydon, S Breuils Bonnet, R Paulin, E Michelakis, ... The FASEB Journal 28, 868.2, 2014 | 1 | 2014 |
| LAG3 expression profile and the mechanisms regulating LAG3 expression and function CG Graydon | | 2021 |
| miR‐126 at the dawn of angiogenic defect seen in PAH right ventricular failure. F Potus, C Graydon, W Ryan, E Michelakis, S Provencher, S Bonnet The FASEB Journal 29, 630.8, 2015 | | 2015 |
| A18 RIGHT VENTRICLE: MRNA, MALENESS, MRI OR MATH: Mir-126 Down-Regulation: A Specific Signature Of Right Ventricle Failure In Pah F Potus, C Graydon, R Wong, S Breuils-Bonnet, E Michelakis, ... American Journal of Respiratory and Critical Care Medicine 191, 1, 2015 | | 2015 |
| Angiogenesis Defect In Pulmonary Arterial Hypertension Right Ventricle Failure: Role Of Small Non-Coding Rna F Potus, C Graydon, S Breuils-Bonnet, R Paulin, ED Michelakis, ... D95. EPIGENETICS IN PULMONARY HYPERTENSION: NOVEL MECHANISMS AND TARGETS …, 2014 | | 2014 |
| D95 EPIGENETICS IN PULMONARY HYPERTENSION: NOVEL MECHANISMS AND TARGETS: Angiogenesis Defect In Pulmonary Arterial Hypertension Right Ventricle Failure: Role Of Small Non … F Potus, C Graydon, S Breuils-Bonnet, R Paulin, ED Michelakis, ... American Journal of Respiratory and Critical Care Medicine 189, 1, 2014 | | 2014 |
| Detecting LAG3: antibody discrepancies in flow cytometry CG Graydon, M Kowatsch, A Balasko, J Lajoie, KR Fowke | | |
